Drug information provided by: Merative, Micromedex®
Nelarabine injection is used to treat specific types of cancer called T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). This medicine is usually given to patients who have already received at least two other cancer medicines.
Nelarabine belongs to the group of medicines called antineoplastics. It interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by nelarabine, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects may not be serious, but may cause concern.
Before you begin treatment with nelarabine, you and your doctor should talk about the benefits this medicine will do as well as the possible risks of using it.
This medicine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Sept. 01, 2023